<SEC-DOCUMENT>0000856982-25-000041.txt : 20250711
<SEC-HEADER>0000856982-25-000041.hdr.sgml : 20250711
<ACCEPTANCE-DATETIME>20250711160725
ACCESSION NUMBER:		0000856982-25-000041
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250707
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250711
DATE AS OF CHANGE:		20250711

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18592
		FILM NUMBER:		251119084

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mmsi-20250707x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 11.0.0.3 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 7/11/2025 5:23:07 PM -->
<!-- iXBRL Library version: 1.0.9292.28120 -->
<!-- iXBRL Service Job ID: 4b11e037-04d0-44de-aceb-1ae6396e9620 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mmsi="http://www.meritmedical.com/20250707" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityCentralIndexKey" id="Tc_XTzXTmSdRE6jRHYAeck78w_2_1">0000856982</ix:nonNumeric><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:AmendmentFlag" id="Tc_Fg8QNh2cpUqNF2rJl-mn1g_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mmsi-20250707.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-07</xbrli:startDate><xbrli:endDate>2025-07-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:50.24pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_ad6ff9e0_3e1b_4c81_ab05_390e6a9d2906"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:DocumentType" id="Narr_SYHr7rXCvEyJJgXFZx6OUQ"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;">Date of Report (date of earliest event reported): </span><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_ZjW6MAswE0O9pwRxrY9cNg"><span style="font-size:9pt;">July 7, 2025</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="mmsi-20250707x8k001.jpg" alt="Graphic" style="display:inline-block;height:50.24pt;width:279.71pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityRegistrantName" id="Narr_E1me_LFpc0Oon0Cm08JM1Q"><b style="font-weight:bold;">Merit Medical Systems,&#160;Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_482e885a_2d52_4623_b7e4_21eef4425b9e"></a><a id="Tc_fRfoSA46UUe7-zwBxhMw3Q_2_0"></a><a id="Tc_9fpZ-LgGEkaxKtTFdEY4AA_2_2"></a><a id="Tc_Wyi5x_emvECbEJNwalajGg_2_4"></a><a id="Tc_fLdQwtp020ePkQ8cJppVhg_3_0"></a><a id="Tc_e_9OXpjU4UeABjaUuuEXeA_3_2"></a><a id="Tc_wVqLEo9Z20qJlNkV8ulVKQ_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc__nFbYZ26yEKRLClZh2FESA_1_0"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityFileNumber" id="Tc_nrhIFope-02ZNhX0cKQAkw_1_2"><b style="font-size:9pt;font-weight:bold;">0-18592</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityTaxIdentificationNumber" id="Tc_qiffewhlvka6f2KjttFPvg_1_4"><b style="font-size:9pt;font-weight:bold;">87-0447695</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(State or other jurisdiction of</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Commission</p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(I.R.S. Employer</p></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">incorporation or organization)</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">File Number)</p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_7d471683_06d1_45fe_9287_288340eace6c"></a><a id="Tc_h7sRF1ngOUuL2AI7eSIE1w_2_0"></a><a id="Tc_nnFFDC7ZL0GrM05QV-v0Jg_3_0"></a><a id="Tc_Jg-sItnrrkyn3OOFSCueRA_3_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityAddressAddressLine1" id="Tc_wcfXDn4UbkCUutfkWfrOtA_1_0"><b style="font-size:9pt;font-weight:bold;">1600 West Merit Parkway</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityAddressCityOrTown" id="Narr_p4Cy_w_SyUaq1V2C3XD1pw"><b style="font-size:9pt;font-weight:bold;">South Jordan</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_21uzuXjx2Ua7fVmQ3SSKdg"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:EntityAddressPostalZipCode" id="Tc_uYEC3T6s402qxprZ3JgwmQ_2_2"><b style="font-size:9pt;font-weight:bold;">84095</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Address of principal executive offices)</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:CityAreaCode" id="Narr_pnHFzEL2r02VjOGInpXv4w"><b style="font-size:9pt;font-weight:bold;">801</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:LocalPhoneNumber" id="Narr_e_n9M2XLr0iGYhwBkSwqBg"><b style="font-size:9pt;font-weight:bold;">253-1600</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Registrant's telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_ywaUSv9lmk27bF1ylwIM5Q"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_kWYEC963fEuauuVIT05m7A"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_AbBoio8n4E28QGsl5rCjgQ"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_hQyuMmltHke-UG0YU_7C0g"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_e1adca4e_7a42_4339_9783_775404ac1f0f"></a><a id="Tc_9fxKExQpR0SKFbowZ1BIXA_1_0"></a><a id="Tc_MLIQkPNWtUClq9iuaAFRGQ_1_2"></a><a id="Tc_hHV4JEsEpU6-Ot2UAwrzsQ_1_4"></a><a id="Tc_Yuku_wfjlkyHQx09C9BHvg_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:20.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:42.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Title&#160;of&#160;each&#160;class</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:20.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Trading&#160;Symbol(s)</p></td><td style="vertical-align:bottom;width:3.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:42.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</p></td></tr><tr><td style="vertical-align:top;width:31.7%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:Security12bTitle" id="Tc_Cid0cSXWhkGVTc-7Zt8c6Q_2_0"><span style="font-size:9pt;">Common Stock, no par value</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.06%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:TradingSymbol" id="Tc_14hUt_h-eE2lKRB8vobfug_2_2"><span style="font-size:9pt;">MMSI</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:3.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.39%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" name="dei:SecurityExchangeName" id="Narr_zjkwjMvbtEKuTQ_zzh9rsA"><span style="font-size:9pt;">NASDAQ</span></ix:nonNumeric><span style="font-size:9pt;"> Global Select Market</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;">Emerging growth company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_x1153saps068VEOj4--gsw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Segoe UI Symbol';font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Segoe UI Symbol';font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_6373cea9_ce6c_416e_82d9_33a18b36fc2e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item 2.02 Results of Operations and Financial Condition.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On July 7, 2025, Merit Medical Systems, Inc. (&#8220;Merit&#8221;) issued a press release announcing preliminary unaudited revenue for the quarter ended June 30, 2025, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The information contained in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Merit makes reference to a non-GAAP financial measure in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K. Reconciliation of this non-GAAP financial measure to the comparable GAAP financial measure is included in the press release.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item 5.02 Appointment of Certain Officers.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On July 7, 2025, Merit announced the appointment of Martha Aronson as Merit&#8217;s President and Chief Executive Officer (&#8220;CEO&#8221;), effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO of Merit through October 3, 2025. Upon Ms. Aronson&#8217;s appointment, Mr. Lampropoulos will continue to serve as Chairman of the Board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Ms. Aronson was the Executive Vice President and President of Global Healthcare for Ecolab, Inc. and previously served as the Senior Vice President and President &#8211; North America for Hill-Rom Holdings, Inc. Prior to that, she spent nearly 20 years at Medtronic in various general management and leadership roles, both in the United States and internationally. Ms. Aronson guided and advised companies as a director, most recently serving as a director, and formerly as Chair of the Board, for CONMED Corporation. She also served as a director of Methode Electronics, Inc., Clinical Innovations, LLC, Cardiovascular Systems, Inc., Beta Bionics, Inc., Hutchinson Technology, Inc., Bright Uro, and OmCare. She holds a Bachelor of Arts in Economics from Wellesley College and a Master of Business Administration from Harvard Business School.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">There is no arrangement or understanding between Ms. Aronson and any other person pursuant to which Ms. Aronson was selected as Merit&#8217;s President and CEO. Ms. Aronson is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In connection with Ms. Aronson&#8217;s appointment, Merit entered into an offer letter with Ms. Aronson on July 7, 2025, under which Ms. Aronson will (i) receive an annual base salary of $1,000,000, (ii) receive a signing bonus of $250,000 and (iii) participate in Merit&#8217;s annual bonus program commencing in the 2026 fiscal year, with a target bonus of 100% of Ms. Aronson&#8217;s base salary and a maximum bonus of 200% of her base salary, as determined in accordance with Merit&#8217;s 2019 Executive Bonus Plan. Additionally, Ms. Aronson will (a) participate in Merit&#8217;s 2018 Long-Term Incentive Plan (the &#8220;Plan&#8221;) with eligibility for annual equity awards and an initial award with a target grant date fair value of $5,500,000, (b) receive an equity grant upon commencement of employment having a fair value of $4,125,000 in the form of performance-based stock units and time-based restricted stock units under the Plan, (c) receive a transition allowance of $12,000 per month through September 30, 2026, and (d) receive reimbursement for certain relocation expenses and legal fees. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_0764840c_be70_4b78_a4b1_16c15ff37cc8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:34.5pt;"><td style="vertical-align:bottom;width:15.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;NUMBER</b></p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DESCRIPTION</b></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:top;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;">99.1</p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20250707xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release dated July 7, 2025, entitled &#8220;Merit Medical Names Martha Aronson as New President and Chief Executive Officer.&#8221;</span></a></p></td></tr><tr style="height:15.4pt;"><td style="vertical-align:top;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;">104</p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:6pt 0pt 0pt 0pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_111f7eeb_2102_42cb_820f_f6e7d4f4d14b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: July 11, 2025</p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;">/s/ Brian G. Lloyd</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;border-top:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian G. Lloyd</p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Legal Officer and Corporate Secretary</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>mmsi-20250707xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.0.0.141--><!--Created on: 7/11/2025 05:23:03 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 0pt 7.5pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><a name="_Hlk54257290"></a><a name="_Hlk529444201"></a><font style="font-family:'Times New Roman','Times','serif';"><img src="mmsi-20250707xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:75.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:468pt;"></font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Merit Medical Names Martha Aronson as New President and Chief Executive Officer</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Fred Lampropoulos will continue to serve as Chairman of Merit&#8217;s Board of Directors</i></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025</i></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">SOUTH JORDAN, Utah, July 7, 2025 (GLOBE NEWSWIRE) &#8211; Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit&#8217;s new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO of Merit through October 3, 2025. Upon Ms. Aronson&#8217;s appointment, Mr. Lampropoulos will continue to serve as Chairman of the Board.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;"><a name="_Hlk202173221"></a></font><font style="font-family:'Times New Roman','Times','serif';">&#8220;I am pleased to welcome Martha to Merit,&#8221; said Mr. Lampropoulos. &#8220;I believe the company has never been in a stronger position. Martha is uniquely qualified to lead Merit into the future and drive its continued success. Her keen intellect and proven track record of empowering global teams through collaborative excellence, consistent with &#8220;The Merit Way,&#8221; makes her the ideal leader for Merit&#8217;s next stage of growth. Since our founding in 1987, we have achieved significant milestones, including strong returns delivered to shareholders since our IPO on May 10, 1990. I am incredibly proud of these achievements.&#160;With Martha&#8217;s experience and capability, I look forward to supporting her vision while she charts Merit&#39;s course forward.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Ms. Aronson has extensive experience in global healthcare. Her business management experience includes overseeing global healthcare businesses ranging in size from $500 million to $1 billion. She was the Executive Vice President and President of Global Healthcare for Ecolab, Inc. and previously served as the Senior Vice President and President &#8211; North America for Hill-Rom Holdings, Inc. Prior to that, she spent nearly 20 years at Medtronic in various general management and leadership roles, both in the United States and internationally. Aronson guided and advised companies as a board director, most recently serving as a director, and formerly as Chair of the Board, for CONMED Corporation. She also served as a director of Methode Electronics, Inc., Clinical Innovations, LLC, Cardiovascular Systems, Inc., Beta Bionics, Inc., Hutchinson Technology, Inc., Bright Uro, and OmCare.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">She holds a Bachelor of Arts in Economics from Wellesley College where she graduated </font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">magna cum laude</i><font style="font-family:'Times New Roman','Times','serif';"> and Phi Beta Kappa. She was named All-American in Division III tennis and Academic All-American while at Wellesley. She also earned a Master of Business Administration from Harvard Business School.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;I am excited to join Merit and truly honored to take on this role,&#8221; said Aronson. Fred has built and grown an extraordinary company over the past four decades, starting with one single idea and building it into the incredibly successful global company that it is today. Working with the talented team at Merit, I look forward to building upon his remarkable legacy and leading the company into a future of continued excellence and innovation.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> </font><font style="font-family:'Times New Roman','Times','serif';">&#8220;The Board is delighted to welcome Martha to Merit,&#8221; said Dr. F. Ann Millner, Lead Independent Director. &#8220;Through a meticulous selection process, we identified her as an exceptional fit for our organization. With her extensive global expertise and profound understanding of our industry, we are confident she will lead Merit into a successful new chapter.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;padding-bottom:8pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dr. Millner added, &#8220;On behalf of Merit&#8217;s Board of Directors, we extend our deepest appreciation to Fred Lampropoulos for his 38 years of leadership and dedication to Merit. Fred is a visionary leader committed to medical innovation, employee well-being, and community involvement. His foundation of The Merit Way will continue to inspire and guide the company for years to come. Equally admirable is Fred&#8217;s philanthropic work, reflecting his deep dedication to the well-being of others. As Merit&#8217;s founder, he has advanced patient care and significantly improved health outcomes worldwide. Fred&#8217;s genuine leadership reaches beyond the workplace and has touched communities around the globe.&#8221;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:6pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Second Quarter 2025 Preliminary Revenue Results</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;background:#ffffff;margin:0pt;">Merit also announced preliminary unaudited revenue in the range of approximately $380 to $384 million for the quarter ended June 30, 2025, a projected increase of approximately 12% to 14% compared to revenue reported for the quarter ended June 30, 2024. Preliminary constant currency revenue for the quarter ended June 30, 2025, increased in the range of approximately 11% to 13% compared to the prior year period. Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial m5easure is included under the heading &#8220;Non-GAAP Financial Measure&#8221; below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;background:#ffffff;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;background:#ffffff;margin:0pt 0pt 10pt 0pt;">As previously announced on July 3, 2025, Merit plans to release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access the conference call, please pre-register using the following&#160;<b style="color:#4472c4;font-weight:bold;">link</b>. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this&#160;<b style="color:#4472c4;font-weight:bold;">link</b>. A link to both register for the conference call and view the webcast will be made available at www.merit.com.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Non-GAAP Financial Measure</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Although Merit&#8217;s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;), Merit&#8217;s management believes that the non-GAAP financial measure of constant currency revenue referenced in this release may provide investors with useful information regarding the underlying business trends and performance of Merit&#8217;s ongoing operations and can be useful for period-over-period comparisons of such operations. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Merit&#8217;s management team uses this non-GAAP financial measure to evaluate Merit&#8217;s financial performance generally, to compare operating and financial results to prior periods, to evaluate changes in the results of its operating segments, and to measure and allocate financial resources internally. However, Merit&#8217;s management does not consider this non-GAAP measure in isolation or as an alternative to measures determined in accordance with GAAP.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Readers should consider the non-GAAP measure used in this release in addition to, not as a substitute for, financial reporting measures prepared in accordance with GAAP. This non-GAAP financial measure generally excludes some, but not all, items that may affect Merit&#8217;s revenue. In addition, it is subject to inherent limitations as it reflects the exercise of judgment by management about which items are excluded. The non-GAAP financial measure used in this release may not be comparable with similarly titled measures of other companies. Merit urges readers to review the reconciliation of the non-GAAP financial measure to its most directly comparable GAAP financial measure included herein, and not to rely on any single financial measure to evaluate Merit&#8217;s business or results of operations.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 6pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Constant Currency Revenue</i></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Merit&#8217;s constant currency revenue is prepared by converting the current-period preliminary unaudited revenue of subsidiaries whose functional currency is a currency other than the U.S. dollar at the applicable foreign exchange rates in effect during the comparable prior-year period and adjusting for the effects of hedging transactions on preliminary unaudited revenue, which are recorded in the U.S. dollar. The preliminary constant currency revenue adjustment of $(2.3) million to preliminary unaudited revenue for the quarter ended June 30, 2025 was calculated using the applicable average foreign exchange rates for the quarter ended June 30, 2024.</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 6pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Non-GAAP Financial Measure Reconciliation</i></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The following table sets forth supplemental financial data and corresponding reconciliation of non-GAAP preliminary constant currency revenue to Merit&#8217;s corresponding financial measure prepared in accordance with GAAP for the quarter ended June 30, 2025.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Reconciliation of Preliminary Unaudited Revenue Range to Preliminary Constant Currency Revenue Range (Non-GAAP)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">(Unaudited; in thousands except&#160;percentages)</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:43.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:19.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td colspan="3" style="vertical-align:top;white-space:nowrap;width:17.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.38%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Three months Ended </font></p></td></tr><tr><td style="vertical-align:bottom;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:40.24%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">June&#160;30,&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">%&#160;Change (a)</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</font></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">2025</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">2024</font></p></td></tr><tr><td style="vertical-align:top;width:43.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Preliminary Unaudited Revenue Range</font></p></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">12.4 &#8211; 13.6</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">%&#160;&#160;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">380,000 - 384,000</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 338,003</font></p></td></tr><tr><td style="vertical-align:top;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:43.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Add: Impact of foreign exchange</i></p></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> (2,300)</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:top;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:43.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Preliminary Constant Currency Revenue (b)</font></p></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">11.7 &#8211; 12.9</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">%&#160;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">377,700 - 381,700</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 338,003</font></p></td></tr><tr><td style="vertical-align:top;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:43.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Amounts in this table are rounded while percentages are calculated from the underlying amounts.</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">A non-GAAP financial measure. For a definition of this non-GAAP financial measure, see the section of this release entitled &#8220;Non-GAAP Financial Measure.&#8221;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Amounts in this table are rounded Amounts in this table are rounded while percentages are calculated from the underlying amounts.</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">A non-GAAP financial measure. For a definition of this non-GAAP financial measure, see the section of this release entitled &#8220;Non-GAAP Financial Measure.&#8221;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">while percentages are calculated from the underlying amounts.</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">A non-GAAP financial measure. For a definition of this non-GAAP financial measure, see the section of this release entitled &#8220;Non-GAAP Financial Measure.&#8221;</font></div></div></div><div style="margin-top:6pt;"></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:20.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:1.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:15.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.99%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;background:#ffff00;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:3.98%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:40.24%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Amounts in this table are rounded while percentages are calculated from the underlying amounts.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">A non-GAAP financial measure. For a definition of this non-GAAP financial measure, see the section of this release entitled &#8220;Non-GAAP Financial Measure.&#8221;</font></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;padding-bottom:8pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ABOUT MERIT</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,300 people worldwide.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:14pt;padding-top:4pt;text-align:justify;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">Statements contained in this release which are not purely historical, including, without limitation, statements regarding Merit&#8217;s preliminary unaudited revenue and preliminary constant currency revenue (non-GAAP) are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to risks and uncertainties such as those described in Merit&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 (the &#8220;Annual Report&#8221;), Merit&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the &#8220;Quarterly Report&#8221;) and other filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). Such risks and uncertainties include consequences of Merit&#8217;s executive succession planning activities and leadership transition; adjustments to Merit&#8217;s preliminary financial results resulting from Merit&#8217;s completion of its internal financial accounting procedures; inherent risks and uncertainties associated with Merit&#8217;s acquisition of Biolife Delaware, L.L.C. (&#8220;Biolife&#8221;); Merit&#8217;s integration of the Biolife business and operations and its ability to achieve revenues and other financial measures consistent with its forecasts projected for the Biolife acquisition; risks and uncertainties regarding trade policies or related actions implemented by the U.S. or other countries, including existing, proposed or prospective tariffs, duties or other measures; inherent risks and uncertainties associated with Merit&#8217;s integration of products acquired from Cook Medical Holdings LLC and Merit&#8217;s ability to achieve anticipated financial results, product development and other anticipated benefits of such acquisition; effects of Merit&#8217;s 3.00% Convertible Senior Notes due 2029 on Merit&#8217;s net income and earnings per share performance; disruptions in Merit&#8217;s supply chain, manufacturing or sterilization processes; U.S. and global political, economic, competitive, reimbursement and regulatory conditions; reduced availability of, and price increases associated with, components and other raw materials; increases in transportation expenses; risks relating to Merit&#8217;s potential inability to successfully manage growth through acquisitions generally, including the inability to effectively integrate acquired operations or products or commercialize technology developed internally or acquired through completed, proposed or future transactions; fluctuations in interest or foreign currency exchange rates and inflation; risks and uncertainties associated with Merit&#8217;s information technology systems, including the potential for breaches of security and evolving regulations regarding privacy and data protection; governmental scrutiny and regulation of the medical device industry, including governmental inquiries, investigations and proceedings involving Merit; difficulties relating to development, testing and regulatory approval, clearance and maintenance of Merit&#8217;s products; the safety, efficacy and patient and physician adoption of Merit&#8217;s products; uncertainties regarding enrollment and outcomes of ongoing and future clinical trials and market studies relating to Merit&#8217;s products; modification or limitation of governmental or private insurance reimbursement policies; litigation and other judicial proceedings affecting Merit; the potential of fines, penalties or other adverse consequences if Merit&#8217;s employees or agents violate the U.S. Foreign Corrupt Practices Act or other laws or regulations; consequences associated with a Corporate Integrity Agreement executed between Merit and the U.S. Department of Justice; restrictions on Merit&#8217;s liquidity or business operations resulting from its debt agreements; infringement of Merit&#8217;s technology or the assertion that Merit&#8217;s technology infringes the rights of other parties; product recalls and product liability claims; potential for significant adverse changes in governing regulations; changes in tax laws and regulations in the United States or other jurisdictions or exposure to additional tax liabilities which may adversely affect Merit&#8217;s effective tax rate; termination of relationships with Merit&#8217;s suppliers, or failure of such suppliers to perform; development of new products and technology that could render Merit&#8217;s existing or future products obsolete; market acceptance of new products; dependence on distributors to commercialize Merit&#8217;s products in various jurisdictions outside the U.S.; failure to comply with applicable environmental laws; changes in key personnel; labor shortages and increases in labor costs; price and product competition; extreme weather events; and geopolitical events. For a further discussion of the risks and uncertainties which may affect Merit&#8217;s business, operations and financial condition, see Part I, Item 1A, &#8220;Risk Factors&#8221; in the Annual Report, Item 1A, &#8220;Risk Factors&#8221; in the Quarterly Report and in Merit&#8217;s other filings with the SEC.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Those estimates and all other forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by applicable law, Merit assumes no obligation to update or disclose revisions to estimates and all other forward-looking statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;padding-top:4pt;text-align:justify;background:#ffffff;margin:0pt;">Merit does not, as a matter of course, publicly disclose preliminary unaudited revenue, whether on an annual or quarterly basis, due to the unpredictability of the underlying assumptions and estimates. Merit&#8217;s announcement of preliminary unaudited revenue information in this release should not be regarded as an indication that Merit considered, or now considers, preliminary unaudited revenue information to be material or to be a reliable prediction of actual future results, and the preliminary unaudited revenue information set forth in this release should not be relied upon as such. Readers should not expect Merit to make similar disclosures of preliminary unaudited revenue information in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:14pt;padding-top:4pt;text-align:justify;background:#ffffff;margin:0pt;">Merit&#8217;s consolidated financial statements at and for the quarter ended June 30, 2025 are not yet available. As a result, the financial information described in this release is preliminary, represents management&#8217;s estimate as of the date hereof, and is subject to completion of Merit&#8217;s financial closing procedures for the quarter ended June 30, 2025. These preliminary unaudited revenue results may materially differ from the actual results that will be reflected in Merit&#8217;s unaudited consolidated financial statements when completed and publicly disclosed. Merit&#8217;s independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, Merit&#8217;s preliminary unaudited revenue results. Accordingly, the preliminary unaudited revenue information described in this release should not be relied on as necessarily predictive of Merit&#8217;s actual results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:14pt;text-align:justify;background:#ffffff;margin:0pt;">The preliminary unaudited financial information presented in this release does not present all necessary information for a complete understanding of Merit&#8217;s financial condition as of June 30, 2025, or Merit&#8217;s results of operations for the quarter ended June 30, 2025. This preliminary unaudited financial information should not be viewed as a substitute for full financial statements for the quarter ended June 30, 2025 prepared in accordance with GAAP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:14pt;text-align:justify;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">TRADEMARKS</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;text-align:justify;background:#ffffff;margin:0pt;">Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc.,&#8239;its subsidiaries, or its licensors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CONTACTS</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;">PR/Media Inquiries<br>Sarah Comstock&#8239;&#160;<br>Merit Medical&#8239;&#160;<br>+1-801-432-2864&#8239;|&#8239;sarah.comstock@merit.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INVESTOR INQUIRIES</u><br>Mike Piccinino, CFA, IRC&#8239;&#160;<br>&#8211;ICR Healthcare&#8239;&#160;<br>+1-443-213-0509&#8239;|&#8239;mike.piccinino@icrhealthcare.com</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mmsi-20250707x8k001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20250707x8k001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !# 74# 2(  A$! Q$!_\0
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M/V@/AI874MM<>/?#T4\3%70ZC%E2.HZU#_PT7\+O^B@>'?\ P8Q_XU/MJ?\
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M1D]C7VOKWPK\)ZSX#N?"<V@V*:"ULT*6D<"JL0VX#)@?*PZAASGFN _9'^"
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M^6,>6^_^>GW7WU\CT(U:*PKKUZOMO9M.-T]&T[0?,M;OWG'6*4&D_>.T\%?
M7P-X&T\P6F@6E_>2_-=:IJD2W5Y=N?O/+*X+,2>?3T K@OC-\/M-^$&G7'Q3
M\"V$/A[5]$*7.JV6G((;;5K$,!/%-$N%+A"75\;@R]>:9\=/C+JVC?%CX?\
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MK],_V!_^3<M,_P"PA>_^CC7YF3$-/*0<@NQ!'?DU^F?[ _\ R;EIG_80O?\
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M'5$@V[?+%SC=TXS][WSS5WPQ^U]\4_"'@N+PQI^OQ_88(O(M[FXMEENK>/&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>mmsi-20250707xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20250707xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !F G8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[C_:G_:K\
M/?LO^%K2\U"V?5]=U)F33M(AD"-+MQN=VP=B+D9."22  >WQ._\ P5@^(D\S
M&'PAX9BB)^5&-PQ ]SO&?RK-_P""JJ2ZC\?=$BWG%OX>A\M">/FGG)_$X'Y"
MOBN"0QL5888<$'M7C5\1-3:B[6/U'*,FPDL)"K7AS.2OK^1]UI_P52^([_\
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M_P#QRODL"@K[4OKN(_G92X4R;_H&C^/^9]:?\/)_B!_T+7AW_OF?_P".4?\
M#R?X@?\ 0M^'?^^9_P#XY7R9MHV^U+Z[B/YV/_53)O\ H&C^/^9]9_\ #R?X
M@_\ 0M^'?^^9_P#XY6==_P#!37XE6C?-X6\-,AZ,%N,?^C*^7=E(\0=2K $'
MJ#5+'5UO(RJ<(Y1)>[ATG\_\SZ<'_!4'XB'_ )E?PU_WS<?_ !RGC_@I]\1#
M_P RQX:_[YG_ /CE?)-[H[1DO!DKW3N/I6>#6ZQE9[2/'GPSEM*7+/#K\?\
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MQ _Z%OP[_P!\S_\ QROD-E:-L."I]",4!JT^N8C^<Y_]6<FV>&C^/^9]>_\
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MN]-W#S5T^:6&8+W*ERRY]B.?45\7:KH^HZ(T2ZCI]WI[3)YD2W<#Q%U_O+N
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M<^RO%<WL:Z?*FWNM%N]4MO(\? S3L5]G#_@F5XF _P"1WTG_ , Y?_BJ4?\
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ML@0DG@,<*3_%CFG:#\#]6UGPQKNJS74.G7&DR3126%PI$A>(9D4\_*1]#ZG
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MGD#->9_$KXO>$?'^H7NL_P#"':A%X@D:,P3WFL^?:P*C#;$+<1*/*"@J$!
M-"?'#PYH$][K/A3X>VGASQ9=020#4$U"6:VLO,4I(]M;L/D8JS ;F8)GBM?:
MJ]N;3YW9YRP$^13]DU4NVO@Y8M\O2[TT5VM7J[*Z+/[/_C?7+GQ!X>\/GXE#
MX?Z!IUT+N,%FBCN':1=R-L $C,.!YQV@<9 K@_C*K1?%?QBKZ.WA]O[5N&_L
MML9MLR$A/EX[]N.>.*VO#OQ.\)6WA_2+'Q+\.[/7[W1PRVMY;7KV7VB,L7"7
M2HI\X D_-PQ'!.*P?%7Q%C\<7GBW5]>TF.\\2ZY>1W<.I1S-&MD QWHL0X8,
MNU1D\!:Q;3@HW_/^ON/3A"<,5*JJ=DU;[/\ -NK.[ZM\VJZ;L[3PUK=_>?LJ
M>/\ 3I[R:;3[+6]*:VMG<F.$N9RY4=!N(!/K6W\'=.\*_#'X?1>._$WB"XT'
MQ)KTDUGX<GL],_M"2QBC.R>\$9= 'W$HC$DKAB%)QCR;2?'QTKX:>)?"/V,2
MKK-[9W9N_,QY7D>9\NW'.[S.N>,5N^'?BUH9\$Z;X7\9^#U\56.D32S:7<6^
MH/8W%N)6#20LRA@\;,-V, @DX/-:1E&Z;W2_7_(XL10JN-2,4^64[NUKM<J[
MZ:R6M]U?N>AVGA;4_@9X6^*NO6>K+?Z\MOI4>E>([-F#M97[-(UU&Q^9'D1
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MY1DP. 1*C9&>#5QA33LW_5[')7Q>-E2<HQLUMHWK[-RO]^B5M_,^>=<TB_\
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M7.@/G=I0O9!:G)R1Y0.W&><>M*,HQ*KT*]>/1.S7R=M?73;\3T+5O ?A/4O
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MA]GHHKDQ5*#DI6U/HN'L?B8494E/W8[+32X@_P""?WQ&_P"@OX7_ / NY_\
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M_B4!_P ACPK_ .!ES_\ (]%%=#IP['A1QV(_F_!?Y$J_\$_/B2N/^)QX6_\
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MF/\ L"_$5NFK^&/_  +N?_D>BBG[*'8SEC\3_-^"_P B"3]@#XCL.-8\+_\
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&CNWJV?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mmsi-20250707.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  11.0.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/11/2025 5:23:12 PM-->
<!--Modified on: 7/11/2025 5:23:12 PM-->
<xsd:schema targetNamespace="http://www.meritmedical.com/20250707" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:srt-roles="http://fasb.org/srt-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mmsi="http://www.meritmedical.com/20250707" xmlns:snj="http://xbrl.sec.gov/snj/2025" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2025" xmlns:rxp="http://xbrl.sec.gov/rxp/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:cyd-8k-sub="http://xbrl.sec.gov/cyd-8k-sub/2025" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20250707_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20250707_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>mmsi-20250707_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  11.0.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/11/2025 5:23:12 PM-->
<!--Modified on: 7/11/2025 5:23:12 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>mmsi-20250707_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  11.0.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/11/2025 5:23:12 PM-->
<!--Modified on: 7/11/2025 5:23:12 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mmsi-20250707.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638878513924188980" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638878513924188980" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638878513924188980" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638878513924188980" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638878513924188980" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638878513924188980" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638878513924188980" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638878513924188980" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638878513924188980" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638878513924188980" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638878513924188980" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638878513924198955" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638878513924198955" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638878513924198955" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638878513924198955" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638878513924198955" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638878513924198955" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638878513924198955" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638878513924198955" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638878513924198955" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638878513924208969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638878513924208969" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638878513924208969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638878513924208969" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638878513924208969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638878513924208969" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638878513924208969" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638878513924208969" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  07,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-18592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Merit Medical Systems,&#160;Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0447695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West Merit Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Jordan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">253-1600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MMSI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000856982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mmsi-20250707x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mmsi-20250707.xsd</File>
    <File>mmsi-20250707_lab.xml</File>
    <File>mmsi-20250707_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mmsi-20250707x8k.htm">mmsi-20250707x8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mmsi-20250707x8k001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mmsi-20250707x8k.htm": {
   "nsprefix": "mmsi",
   "nsuri": "http://www.meritmedical.com/20250707",
   "dts": {
    "schema": {
     "local": [
      "mmsi-20250707.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mmsi-20250707_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mmsi-20250707_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mmsi-20250707x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mmsi-20250707x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mmsi-20250707x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000856982-25-000041-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000856982-25-000041-xbrl.zip
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MT/X[HVN^$)N#I4^VQD_$36J+&3R@S?+7%%JII40>DOC(+RJ4.63ND-NW!NA
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M9*@E.8]S*5W5P#H+D%^ 5^+K,.*,CF<;4/;JK-ZJ?23-5J55:[[;[:P2_\\
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M3=F;T ^L[G@6S*K)]+[8;D<'X%N P8&I!!UO1#K,]H:(37R).(_\]:)T3+H
M/ B,Y8/T!,PU -6!!]AV0CN@+O-"WQX3'S23WQV+ZG$%KP. Q N,4;NIK2$A
MM -D=,?)NZYG P18#YT>"]?'_?)R"+@0-6M P9D3':(S'HJ+(1>/+!=7ELJ2
M*+3:-,6.Y]D="@0+@'?24\P7;@7 (YCC$+KQDI>?FF?&0WK5O"W93E\M= Z4
ML3VLG^8N%V$_P5^3]3Q&KNJD.79 !\US/%*B5-"TO?LV'CZT<?%N?"J&'U"6
M'@ 9I':S-D*;184U-1?S\=P&5MRWNJT42/6@0=2LG(&";Y?,*=G\$SA%%-IP
M_8MS?=.S+1U([_9.09^"4K53+-__ LYP*9_MUD(:AI_K+3GG%"KKP_+1[^D0
MB!./X1ZN5S0J*6J*\6>V:T_87I,S4<D-Y__!G'_!&>IZ/-%+'&Z!Y@$_[W9G
MG(M*9]^SO**KU=3BY:%OYWCUIK=&2C_Z#4.1]-18GC8'*)HAJ=N=^"R#)PE%
M5&$C%G^/6-1]/V1\L7"8E^/PU+&#3WTF71W*7Z_:A:J\\,2%WU XLDS2MO5G
M"$=<8=G"\;,,]?K"\10O+V6)1AX7X^"S#>Z>R$(4U$2)!P;$>$F'ZQZ$+Q.[
M<:X:4ZBA4XVU"U13VUHV6VJ7"L5LNU#(:;)&=:4K=^_NQQ\=UT:7@X;</#[H
M>,-ORG[].EG$GREY>E*_[%^<?0FNJO;WDA72RD'C\#+>#3.;__;ILW94\VN#
MJ[QT'JA7E2'_X5_&&QMF2GX-^V%[V+VQ^^-/ER.Y5"WM?[I-[_%_M:RVP9V<
M-B0D0B/9=.R%<:4H*%]\D2WW2N;>%9I-<L_RLMJT>[-F-UA?&M;E33+A*Z ]
MF\EF-UA?>0JGFLEN=,SKI6T^-K&N8CFGA8?#)^?^17\9U<WHDVY3WW]^HL/#
M$]?ZYC8^JOQ70A!.L<LX""@<RNWG9YL\IE#7EPB/*J55$ &/B+M/*%CL*\?O
MXU,TAZ:5%)BZ>,_)B@J\P8Q:2!V]O>AD[F4G$KU>-EOL+(\5M2.4TR2'K6H9
MLMZ\_F+V#S^W=*GP+2CJ^>0LMX=B*!CY =^Z&7AZ?X>X'AE03FZI';*'#L=\
MF&>GY%JZOEM]8E=J<)%*_&N9,=;&D1Z><**BF5=!VY183;6/&_O%6Z_3#7MQ
M-N5#G'AZVJR_!,\M7;V_)L_%,\!?RW.) DR"LG/GE?ZXZ0]O3F\[0>TX;%VV
M?_PP2]Q?N'R98KRS2O-CY?)G M#DT/8Z>,8ILYD>D%/*^RQ8O)]B58F5ZQ3:
MK;MX!"SF[(R)+I)YX'6?#$TFS@*92[*Q? +#8(#V'B[L]K@W#$P,W0\P\8;Z
MQ&!=RXW.9L6H/='D'+E['O?T&.XLV4:CH[ GLAJ2PI8XU76 I[IBBI9H":93
M25W0UJ*SO2>-X@K M%ZJV<Q?F CTDW!&8E1;3//[K.;[K>FE'US^\$):M-<@
M&<VA&$PU&DM*1XT4)9?UZ<"7\\7/M?,;39)Z_G"9:VBO3N9U6W.J=Q]0-9AW
MNU!O67?R DW02D+U@U9R/;%8%?I,E ((XNQ#O$A/Q&](="L6\I/HRQYCYW@'
MI$@M=&%T\(8SP!34 UU'71TS6ZBNXZEY6!BOOC,H-_PH[]"X;Z4LNTTG*V5I
M)98AS^"RNWSUBGST1%E8<Z6WCJ-XB@ _XP:HEUV/??(-78NNX$I;R8/1BN[G
MFKD.,GWQV!-P_1/8DG\R)(N__S$3<*9Z'Q1AZ!JX5NOQ<H*HU+UR\4A408T>
MDZ)X-NV"U5.F]I"._=A-*90RV<1+*4]PC5=HDNB6/I+ZC*AXC=O_Q(V>KWSU
MWV]RV=_6NM[L]\N8C;,P\ME"5F>TU,:C@=J:DF?MHFJ4VMDL58J=;+ZKJ\G]
M"2N8.T@D'-,]@0]M<JD'S"%J1E9)@_FA'8C=F>=@:\393F QD(.),5'UP+C!
M%YGE75+T^(#.79*^AV>'++XSA.!U(>AP%555WA-EQ&=E[RVXBWX(Y@\%2PAW
MI *7,0JV%W5=T&%ZM#6#V98#(^=C$KHTA'%#!8X7'H5,6&%H'GT/Q14?)++6
MCD*7@6Y*P,)-5P.QZT/$L-%'[8;<M7P3NT8'T00F"TBIE%'0 !-^8#7D'+/.
MXBN7P![#+2JD*!VOS#.<QW<+!FJYD^N<A5-$$V=ZRD"))WO_",CV=%/:S.!I
M$% =L0*>/0N\M\0WP4425G&'@>L.QK9!8D)V+9L9,2$%'<"&!77!!.=.;-CB
M$QWR'20$=2+Z;6.%N)MTX81M=B9'D0[!RB9^V+G!R(T@'2.V187*L")0 I."
M21'!@[%Q'@_*2H]I>C@A? &'87)I,*(6[?IX@]&]>R_B8$5Z& +*>=M]!WP*
MG0W$135L)+@>)&CB!T#7\?4U^BP,?@B,2V,P7HT#(P%W:%_D^27@ =XI(-:5
M#BN5BY3+XX LAUR CVB8$_&$U7Y" .$9\+X.N$CM]8(J#\ 0\X;P#KG(;+L/
M6#_>L1F)U1W 7PWWCT\?.93^RF#@66X@,F8!+U7&44>0<[&IG_OK.&'$VA[=
M[&B;8'H IZ#834HJ'&9!(#5PRV0&40I[/KD XHCKLL44634MU@5^2LXRB(<]
MF7VJM?.I$F'=+JH%+*8'7@>*92/ ,N0 TU<O,N2$.KAIT0MMSP<G']0&9P[B
M$^"HFM0"53S9:KCO@4^_,P]0[5R,0@PT,,$T[YEWN[L:P-!._4PRS,GH4L@
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M)&*:R"\=%@P9F]%FT<AQW[58,0*G!A^F0YZ173ZO)?PD*ON8TJ^=SW*] #-
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MY-&83RDC*YG4RH!P#'$*B'1\'%E[\;#/ZZ>NW04#9L/G)AO=_3W!F(#RI?;
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M[R:$WWJ6L3@??)+PO=OQC#'\,0/'_O _4$L#!!0    ( .N ZUK;_XO$=RL
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M+EI+#FN\;$/%G=E?,A8L)G3W)T2%4L?SF;]HQ2D4RVYESF\0@;33FHNQIT3
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MV8BELV%,T*%=1D5N_WU4M3<J]URHEQWQXU*%AN59-)^.Z8=;]HD1'9\I3WX
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M7^]H2>H<*/6&!G#OW7V4@>J%_;EKR9+X$?DQH"HABW"U%K.+Y)<=I1FF0 V
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MRD0A(9A,0K$_BM1 ')RKH""AB4^#012H[ &M=5Y$T;>(B.[<B7(L+\!8;S-
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MZ;ZDV,H'T_+;*G=3V7Q#?,@N6M"U7EZNK77',>$>;'>&%7.Q'7+J;/:Z71_
MW4Z^Q?A)R-WV[J&08Y'"- V;G9BH.-!CY0T-[[#R&GPY+-_(*%Q014N4H_6!
M+L 2%CL& EV>BI$DPSR#ROM*)8+L!ZN&KH=XRT?TEI\R,L"EZ,]"P1$!0W$T
MB.S2R'^<*<$H-$\Q*/("7D2V%F9DRU%N2IL(A2D"8![6]PXSG=K)<Q7','R^
M!SL [HD\D\$I;#O0-@2H<:HGF"@9>M_-E1R;TH(#'<>RKS-F($*=!S0D'+=!
M4YL(: "]<,;@Y'*"I=J5_RZGI2S'\A1:&BD+N?":&4@0#L][]CGI6B+AP J'
MF9[DHY8XCC"MT 7=421$F$B\G>TM0-A$0?+D$,&(5 )IP"PAS4!B=; 397*=
M*, 6QH@+OM=J!9* 5!,C0B@3:K/B-TA,U @\1&4&0_EY#S_#Q>&^P*L.(D1G
M>[O=$FQ5N 2W1GWH$7(N0N>-IEP1^;5I_?4OG9?MW=])6M8"RBVK\Q0B(,&R
ML@*9RGX41SF@\E#$6I^2F"84MFEY!< BRVD7)-&SR,"HQ&2$?6+IBO.JO(3+
MWO8NV4F!5,L/TG)J67Z8^ HOKZ JNR'F5;!0MMI2N+ 89^:SP&1=IE] T7 @
MF&H"R^,H5+N1# =K@!=!DJKB,)40YP?!=9E,ALY&23IBD.FQ^.E%NTWV&)/"
MH,F?.J)O7\&^H;F)-.P@LQCV+T2PN4@S>P4K^]6NX=UL#>1/!W!;V7=1VGJ_
M.HMT86"@'#I"X68Z5DF$&ZZ<QE.!CS"ZD=@;0R:!Y'G>8?%-:$2\@[-@MYX8
M?,YH4 8NB7A&1FE2&BI!]HPU=-MBBK\0]IA:D"M& 8GJ3&:T3#%4B<JPKXHR
M:$T6,LPH2D6F8W)HRL3I1MK+EX0)WG$N<RB KB<(S!))H"OC>#HSD&$1$=NC
M:V0(!\+?%L(CNA/_P\#D;:%CR TQUB8GW,12G!!)NWSI["(:#W*!A'"-C\YS
MM('DMO_IXX>#-V)?9RE#J]>_C(VN*&@VM*46^4B', ["=):8$W=#[,/MF)\=
M@E>=\8#X[/W[?7R$22.\9X(BEEF=P#7$:ZK#O(YJ@[TK<H 6B^FD0MG<#5QN
M$%\R;7?[:;Q/+K122$*:(/0G!;P&@*O8*F"/4!6V!N]*]!@2LT[].X5$$ZLI
M](F_$+4F@&4+Q<-,A@47R+R$[C#?&<MA(D50C$6,Y$9QMO(M^[9N/XJL5?P3
ME%3.8(D86BCVX.\. )C=O(E<]#D\/ 1S2)+(.MY> $>%B.HWV! %GR]%5C%[
MX$%"9H_0:'*;/+SVF+P7(HT#V;"^8L7^3F9GY*+E1<?!2.MXM4RQ2EU!OAC?
M *M_(%<0/MW%.QFE<B-8I2,P.>@6495\!'T04M9)K4-!E_U0L.P746S'(KH%
MUII0_,PD6*+-GSW!I?#':)9"2\3$,E G4C;@ Y3-LA+F@R!<Q)V&L>5[/#A-
M8YE;A=A6R),CL8,B]L'5STN!A.\R-F-LB=]U=EI.1N/ +0#.)  P6!M9B,Y?
M0*#*9124CK&,D.QEI[*/Q<*#93 MPPU=5F7XO&SIV3B,=$;!9^S8!1^/Q2O(
MM^#*N6J:5 9J!^2B.<ED2A!RA_G:B8^9I'3BY]CC5V1N;Y"YO47$3^ IH"D)
M%0+>4UYUF(0JI6H/5N@K8*U9^F+S'BG&)'VD?& C1E'()>0!NR<#Y8R#R9%-
MV8B&4[Q.V 92RS?$(,HYVI.3Z&P(<O%O%^LY!:";9B35V3M3SCPRRB=MG.P@
M323>DTN;]\#J:,PH":'A;,JK(>H'4QQ8RD:QAXL&\YFDK/H8E5"0+*2 VX<T
MT;EZ-Y6QK[3:;P51L@1G F![X'T-K^U/"?+TD8P'-RF2LIA98:&PN <S @@B
M3N**R(8FB'BQ2$M&0"C3VW*T%\-6J"RG]%Q@\T/P4AP\4T1U.1X!L<N:8?_C
M*'?^,';5N1GB-"BQC_54*7*6N-FGA,4R-KJS %,F*#O3L<U-D0-%QB;6=A%8
M82V37RQ!@2&FD2M(,)VNP21MV>X5EY*SML0!E3B(%R.89PRUF)*V6,H\!3]
MQ@X73$$=)@#X!I!YP,Y'R2[C@$KGA$73SC;)SH&W,DH'YVN&O$$" F)XY+#A
MF>V$IAB->Z#2[:A20,"2HS&73T*7ZT'].>W)T!KC<(+-M^H[0?Y2P.QK"8LB
M*HE0JZ::8C:M&CM,8^GB!2THUP4NFBF)TY&,(8!N()!0%[FJ[7_:?XXR[RA]
M&9P.^>XF$D*=[?RES?_9K70QZQ\X-^W.N6W;>:-W66Z[NK>J+57W5JVC.M^M
M39'0-?N0QFE3#H \.S*>R*EQ7:W-EZV-S9]W^R >*G/MU?9<#W:I>[M?T_JZ
M"3J^O!@=9ZK=^<N _S,'F/7&7+VW=JP",L'?7.>#&P"?*\V2(]<B.5*FB'-S
M3>_LFW=\B^TY[DMYPZR5<'6_QQ4)J"[#O(U@6Y]'8V1G\/"?>EMMKLCTMC;*
M"LT-6D34], X?P"B"*N)RDISP?B=[L\T?&?C9PN1CJC[Q66**GHJO,&4&ZV:
MKJ@,FU.9,RBR#-QS^C4-KD:YXO :^70Z=OV]^OHY$^!B#X&]H'*9#EM(A"];
M%$>S1"?-7_?V/H,A)<#?B H]6$1!M;@]+D[CS3@J(Q&G,0O7<A!"1LZ5&5LH
MB5VB8L/+_!0OW'V1\>4\1ZQX&R-']ATU^.C7^+8<X(.]W[/,OHKUI'5'CC&/
MN+=UC,LZ+17 =L#R8O8.83.]))9AR\X[HPA$*7%DO-V[ 2]\<!C@9*;3+K.9
M/5,M<\Y@ 3;$K<Z>MWD+'@B\B;$^R#TAMJ69M606^VZ( 13(+/\!WU.^XF=R
M'9P*RBQ53LOX786),LA>7?/5#]":7Q)5GW@]H&C4N\B8VJN,<TLPO=@F]YA!
M(@VB!NK3R\9^1IGPBYUV6Z2M,4@8%U<2\72C?&L?Q">3<4/TRK<^0'2YC!++
M&+OE^Y]E0*3H64N< '@YCW"LK[:ZAFNSD3Z:F1I&7-"A.HW-I0<ZANO@E6V(
MS&*5(R,;&YO=8..B4R$PFE,*1RW$IB$7A)*\[-<&BA(I3H*RL04/+@Z$T&<3
M\!8J["DF7BBHV0/2V ^HBL%\+R8&&RKHBRI5?>6V1Q#AUAV9;U@N39F<<O&!
M*M:E4+QYS>N7UG06P9DLN[4+Y7UB:6.02B'/L!G&.2AX,IFTQIPT /^NPJ2'
M*#"\O(^C9Y?C\5T>[;GEC@F^[Z+<MX?D@LL/<VE+N65#O0UN)G+"#_^RH9@:
MS0'U="F=L59/KXN$$R=$:-P.GRP;*P20 54J9H&_WCVA<K=K]#QU$9&D[V+?
ML\;<"BM]&M<6-[9D1R-?'NY=_>P2KH#4S[J$6R/7Z2RPC"5W6L_(:3U&&KOO
MPBBJ;40)-6(L"L#;J OBT(=#?CREEV73+\<\H2U=@\/PG=SUG:\*Z&2H.<G$
M5;;-XOJU#!EN:O)IRX2:5"YMVK\=,XD,W82!#3*]RC@ML1S5P;LRY4OM@ZNS
MA6$#@4:O, Z I3J3,?5/+G6(JK9*VVZXH@/YAA<Q->NH.[<0X'&I9;!63:91
MFS<8$1\V)3MV-T%_%)YG8QLU9+>T$9-K,G83W&)$N MHM-KLNL@"'IE[E-R>
M?*<G='CD"N\*M2*9Y?;XA>6N52GZ:;%>6%KL*+2O3LK8]4//5&6-5%7!^T@H
M+D82&GA)VBIW99U'MBXC#. V#JO"5(NR+,P%"$1R0J+NBE -U@FW;$W1Q]+S
M(N<,K%'3N3^V40K^*@!GL8N3:YQD!NCJW!U1,'JL&L"VW"Z*^%A$35^+R 2=
MD@_$S5F9@]V6.)QMK>%Z+M@4I;BV[D?=38B>4M#<@Z"A"UVMSG)"=:ZR(+)D
M^(\B'-K@,*VU]/L:BYR,(B"A72$YK-M'V.(*Y!5;OU OM#W:=E]54T$6J,&"
M8SY_P%\P"&=J\#7#V2$ 3\F+C+P_<^9B,W9/RRY*5*]<\-<FK*4ONV25!.])
M.>W1)B]32@:HYNJZ;5\#I&4 !$14L*T2EI;#[RN4\@X;Z&698M]3#U?Y6H*#
MO_<3AR\G6U$%C/I<5CI3%JPX/>'+<T]EKJZT,;GI U CT!TJDH\H)QX@&W>-
ML7)RK@:5KZP+ J0<(6T=MQ#O8CJVXIBD3%-HCGT%V IY<L.-0[3(F+<"#NQI
M7Q$66:UW:UV,0WVS4JQR9X!8"[C<YV-V$&./,(=\DHN232,#"WC<"[Q"" T'
M:P1H]K1EA6G/-F8Q+KU1/<\NTA^/_NEIM]5[5CU,]LW'W?F<![)/.BF45Q+?
MFMPES().9EXB_YO4+]>-BV5L7#Q>&+^\-  \KX;H%8+UDVH93>3LFD;9>B51
MG0(>RR2+SR%XL80REZX)#' QJ;;G"1:)3$EB;@9-OF5=B3/5\1<9R76\]R9P
M=<?49/O;%7IWU:ZC!8U4>SY?2G0O.W4,P5!#];)+Z8V[_*EWG&=W6$+[>C%^
MJRL\+<6Q:R.L+K"TT+BS.+9HBV!/1W<!X>;9O7]C\GYW?)6LRZ_:50_7W+"M
M0P&%5_SW)Q21Z/O8%E9<3+:1C;\0DAJUX_^HBH*:U6XM%(CHN B$7@]T-I16
MH]SL.ZT<LVCBD@GXG5FAY:%_G\DIN(J3,8*T_UILK[6]_7-5V&XR+_A*W*P,
M3H6Z =#42\B_YH-M.S;J3R"!:V-Q^;GL&QT7^?S7=OT6[\OPYN"IW6J_N(N(
M4YGVMD8WW\QKMR^VPRHE?)Z'UVF]<A QT7P,T0JZV^J\6-O!V@ZV6R\[:SM8
MVT&WM;6QMH.U'4 ::SM8-3L &86JP5R[3VYE$]M<O%D;Q4H9Q>U(X]H.UG9
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M4$L! A0#%     @ ZX#K6K7I??AG!0  [CL  !4              ( !Y0,
M &UM<VDM,C R-3 W,#=?;&%B+GAM;%!+ 0(4 Q0    ( .N ZUH1&%WM=P0
M /LE   5              "  7\)  !M;7-I+3(P,C4P-S W7W!R92YX;6Q0
M2P$"% ,4    " #K@.M:[I=V.@P;  !=O@  %               @ $I#@
M;6US:2TR,#(U,#<P-W@X:RYH=&U02P$"% ,4    " #K@.M:V_^+Q'<K   +
M+0  %P              @ %G*0  ;6US:2TR,#(U,#<P-W@X:S P,2YJ<&=0
M2P$"% ,4    " #K@.M:>/[SY"HE  "Y%P$ &               @ $350
M;6US:2TR,#(U,#<P-WAE>#DY9#$N:'1M4$L%!@     &  8 D@$  '-Z
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>mmsi-20250707x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mmsi-20250707.xsd" xlink:type="simple"/>
    <context id="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <startDate>2025-07-07</startDate>
            <endDate>2025-07-07</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_XTzXTmSdRE6jRHYAeck78w_2_1">0000856982</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_Fg8QNh2cpUqNF2rJl-mn1g_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_SYHr7rXCvEyJJgXFZx6OUQ">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_ZjW6MAswE0O9pwRxrY9cNg">2025-07-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_E1me_LFpc0Oon0Cm08JM1Q">Merit Medical Systems,&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc__nFbYZ26yEKRLClZh2FESA_1_0">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_nrhIFope-02ZNhX0cKQAkw_1_2">0-18592</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_qiffewhlvka6f2KjttFPvg_1_4">87-0447695</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_wcfXDn4UbkCUutfkWfrOtA_1_0">1600 West Merit Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_p4Cy_w_SyUaq1V2C3XD1pw">South Jordan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_21uzuXjx2Ua7fVmQ3SSKdg">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_uYEC3T6s402qxprZ3JgwmQ_2_2">84095</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_pnHFzEL2r02VjOGInpXv4w">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_e_n9M2XLr0iGYhwBkSwqBg">253-1600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_ywaUSv9lmk27bF1ylwIM5Q">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_kWYEC963fEuauuVIT05m7A">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_AbBoio8n4E28QGsl5rCjgQ">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_hQyuMmltHke-UG0YU_7C0g">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_Cid0cSXWhkGVTc-7Zt8c6Q_2_0">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Tc_14hUt_h-eE2lKRB8vobfug_2_2">MMSI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_zjkwjMvbtEKuTQ_zzh9rsA">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_7_7_2025_To_7_7_2025_G0cGZt271kqJRKsPYRKwyw"
      id="Narr_x1153saps068VEOj4--gsw">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
